Chubb has expanded its global clinical trial liability insurance coverage for institutional research organizations such as hospitals and medical centers, universities and colleges, research institutes, patient/disease advocacy organizations and physician practices, which represent a growing sector of organizations facing risks associated with managing clinical trials. Historically, Chubb has provided clinical trial coverage for institutional research organizations through its Healthcare Industry Practice. As these nontraditional research organizations have expanded, comprehensive standalone clinical trial insurance for their domestic and foreign clinical trials can be secured through Chubb's dedicated Life Sciences Industry Practice, which provides specialized insurance and risk management solutions including products liability coverage exclusively to this industry.
"Traditional life sciences organizations such as pharmaceutical, biotechnology and medical device firms are not the only organizations exposed to clinical trial risks. Institutional research organizations are exposed to many of the same risks, including significant product liability claims, as well as problems related to inadequate insurance coverage, all of which can lead to trial delays and costly setbacks," said Stephen Harris, Senior Vice President, Chubb Life Sciences. "At Chubb, we recognize the world of clinical trials is evolving. To continue meeting our customers' needs, we have expanded the availability of our clinical trial products and services to help non-commercial enterprises manage the complex risks that come with trial activities."
Chubb Clinical Trial products and services include:
- Coverage limits up to $20M
- Worldwide coverage, with locally admitted policies where required
- Industry-leading global certificate of insurance issuance capability, minimizing the potential for costly delays
- Specialized clinical trial knowledge, underwriting expertise and risk engineering capabilities